Perceptive Capital Solutions

FRNM · NASDAQ

$12.77−$0.33 (−2.52%)TodayMarket closed ·
Prev close $13.10

Who owns FRNM

Largest institutional holders, from their latest 13F filings

The 10 largest institutions hold 59.2% of FRNM’s shares.

  • Roche Holdings, Inc.17.4%
  • RA Capital Management, LP14.3%
  • Perceptive Advisors LLC12.4%
  • Horowitz (Andreessen)5.2%
  • Next 6 largest institutions9.9%
  • All other shareholders40.8%
Top institutional holders of FRNM
HolderShares% of shares
Roche Holdings, Inc.18.69M17.40%
RA Capital Management, LP15.37M14.30%
Perceptive Advisors LLC13.31M12.39%
Horowitz (Andreessen)5.57M5.19%
Andreessen Horowitz3.33M3.10%
Ennis (Riley Charles)2.78M2.59%
Farallon Capital Management, L.L.C.2.25M2.09%
One Fin Capital Management LP843.48K0.78%
RTW Investments L.P.742.50K0.69%
Adar1 Capital Management LLC674.70K0.63%

Largest mutual fund holders

Top mutual fund holders of FRNM
HolderShares% of shares
ARK Genomic Revolution ETF762.55K0.71%
Fidelity Growth Company Fund397.34K0.37%
abrdn Healthcare Opportunities Fund355.45K0.33%
Fidelity Select Medical Technology and Devices Portfolio316.76K0.29%
abrdn World Healthcare Fund223.12K0.21%

Insider trades

Form 4 filings by officers, directors and large holders

Insiders made no open-market buys or sales of FRNM in the last 6 months.

Latest FRNM insider transactions
InsiderTypeSharesValue
Elliott Aaron MatthewTax withholding71.92K$1.10M
Waksal HarlanOther30.00K—
Waksal HarlanOther30.00K—
SONG KENNETHOther30.00K—
SONG KENNETHOther30.00K—
Perceptive Capital Solutions HoldingsOther2.07M—
Perceptive Capital Solutions HoldingsOther2.07M—
McKenna Mark C.Other30.00K—
McKenna Mark C.Other30.00K—
ALTMAN MICHAEL SETHOther2.07M—

Short interest

Settled Sep 30, 2026

Shares short
3.40M
Days to cover
3.27
% of shares outstanding
3.16%
Average daily volume
1.04M
Change since last report
+100.4%

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.